LON:HLN Haleon (HLN) Share Price, News & Analysis GBX 338.40 -1.70 (-0.50%) As of 09/19/2025 11:53 AM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsHeadlinesInsider TradesBuy This Stock About Haleon Stock (LON:HLN) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Haleon alerts:Sign Up Key Stats Today's Range 338.20▼ 342.4050-Day Range 338.40▼ 369.2052-Week Range 335.10▼ 419.50Volume57.38 million shsAverage Volume24.24 million shsMarket Capitalization£30.29 billionP/E Ratio2,026.35Dividend Yield0.02%Price TargetGBX 436.67Consensus RatingHold Company Overview Haleon (LSE / NYSE: HLN) is a world-leading consumer health company, with a clear purpose to deliver better everyday health with humanity. In July 2022, it listed as an independent company on the London and New York Stock Exchanges. Haleon's product portfolio spans six major categories - Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin Health and Other. Its long-standing brands - such as Advil, Centrum, Otrivin, Panadol, parodontax, Polident, Sensodyne, Theraflu and Voltaren - are built on trusted science, innovation and deep human understanding. Read More Haleon Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks47th Percentile Overall ScoreHLN MarketRank™: Haleon scored higher than 47% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.9 / 5Analyst RatingHold Consensus RatingHaleon has received a consensus rating of Hold. The company's average rating score is 2.25, and is based on 2 buy ratings, 1 hold rating, and 1 sell rating.Upside PotentialHaleon has a consensus price target of GBX 436.67, representing about 29.0% upside from its current price of GBX 338.40.Amount of Analyst CoverageHaleon has only been the subject of 4 research reports in the past 90 days.Read more about Haleon's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Haleon is 2,026.35, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 279.98.Price to Earnings Ratio vs. SectorThe P/E ratio of Haleon is 2,026.35, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 76.48.Price to Earnings Growth RatioHaleon has a PEG Ratio of 1.49. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioHaleon has a P/B Ratio of 1.86. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Short InterestN/AShort Interest LevelN/A Short InterestThere is no current short interest data available for HLN. Dividend1.7 / 5Dividend StrengthWeak Dividend YieldHaleon pays a meaningful dividend of 1.99%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthHaleon does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Haleon is 39.52%. This payout ratio is at a healthy, sustainable level, below 75%.Read more about Haleon's dividend. Sustainability and ESGN/AEnvironmental ScoreN/A Short InterestThere is no current short interest data available for HLN. News and Social Media2.3 / 5News Sentiment0.15 News SentimentHaleon has a news sentiment score of 0.15. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.79 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Haleon this week, compared to 1 article on an average week.Search Interest3 people have searched for HLN on MarketBeat in the last 30 days. This is an increase of 200% compared to the previous 30 days. Company Ownership0.8 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Haleon insiders have sold more of their company's stock than they have bought. Specifically, they have bought GBX 0 in company stock and sold £315,441.44 in company stock.Percentage Held by InsidersOnly 0.01% of the stock of Haleon is held by insiders.Percentage Held by InstitutionsOnly 25.47% of the stock of Haleon is held by institutions.Read more about Haleon's insider trading history. Receive HLN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Haleon and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. HLN Stock News HeadlinesBENEFIBER MAKES FIBRE CONSUMPTION EASIER FOR CANADIANS WITH LAUNCH OF NEW PRODUCTSSeptember 17 at 9:59 PM | theglobeandmail.comHaleon (LON:HLN) Earns "Buy" Rating from The Goldman Sachs GroupSeptember 12, 2025 | americanbankingnews.comTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger the biggest forced rotation of capital since World War II. They reveal why Trump is mobilizing America’s tech giants… and name the two stocks most likely to soar as trillions shift behind the scenes. | Porter & Company (Ad)FTSE 100 closes lower as consumer staples, industrials drag; corporate earnings in focusSeptember 10, 2025 | msn.comGoldman Sachs upgrades Haleon to “buy” on improving fundamentalsSeptember 10, 2025 | investing.comHaleon upgraded to Buy from Neutral at Goldman SachsSeptember 10, 2025 | msn.comHaleon PLC Announces Share Awards for PDMRsSeptember 10, 2025 | theglobeandmail.comDoes Haleon (LON:HLN) Deserve A Spot On Your Watchlist?September 6, 2025 | finance.yahoo.comSee More Headlines HLN Stock Analysis - Frequently Asked Questions How have HLN shares performed this year? Haleon's stock was trading at GBX 377.40 at the beginning of the year. Since then, HLN stock has decreased by 10.3% and is now trading at GBX 338.40. How were Haleon's earnings last quarter? Haleon plc (LON:HLN) posted its quarterly earnings results on Thursday, July, 31st. The company reported $8.90 earnings per share for the quarter. Haleon had a trailing twelve-month return on equity of 6.54% and a net margin of 9.66%. How do I buy shares of Haleon? Shares of HLN stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What other stocks do shareholders of Haleon own? Based on aggregate information from My MarketBeat watchlists, some other companies that Haleon investors own include GSK (GSK), Micron Technology (MU), NVIDIA (NVDA), AT&T (T), Cisco Systems (CSCO), Meta Platforms (META) and Unilever (ULVR). Company Calendar Last Earnings7/31/2025Today9/19/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryConsumer Goods Current SymbolLON:HLN CIKN/A Webwww.haleon.com Phone44 1932 822000FaxN/AEmployees25,408Year FoundedN/APrice Target and Rating Average Price Target for HaleonGBX 436.67 High Price TargetGBX 500 Low Price TargetGBX 370 Potential Upside/Downside+29.0%Consensus RatingHold Rating Score (0-4)2.25 Research Coverage4 Analysts Profitability EPS (Trailing Twelve Months)GBX 0.17 Trailing P/E Ratio2,026.35 Forward P/E Ratio17.35 P/E Growth1.49Net Income£1.07 billion Net Margins9.66% Pretax MarginN/A Return on Equity6.54% Return on Assets4.45% Debt Debt-to-Equity Ratio53.36 Current Ratio0.84 Quick Ratio0.93 Sales & Book Value Annual Sales£11.02 billion Price / Sales2.75 Cash FlowGBX 15.41 per share Price / Cash Flow21.95 Book ValueGBX 182.02 per share Price / Book1.86Miscellaneous Outstanding Shares8,951,892,000Free FloatN/AMarket Cap£30.29 billion OptionableNot Optionable Beta0.19 Analysts Agree—These Gold Picks Outshine the RestUnlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free Report This page (LON:HLN) was last updated on 9/20/2025 by MarketBeat.com Staff From Our PartnersPrepare for the “Mar-a-Lago Accord” Money ShockWhy Are Wall Street Insiders Moving Their Money to This ONE Asset? Something far more consequential for you...Stansberry Research | SponsoredWhat The Silver Boom Could Mean For You…AI, electric vehicles, and even global central banks are quietly fueling record demand for silver. This once-o...Goldco Precious Metals | SponsoredREVEALED: Something Big Happening Behind White House Doorswhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Haleon plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Haleon With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.